NCT00713193View on ClinicalTrials.gov

Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

September 20, 2017

Study Completion Date

September 20, 2017

Conditions

Thrombotic Thrombocytopenic Purpura

Interventions

DRUG

Cyclosporine

2-3 mg/kg orally in a twice day divided dose for 6 months

DRUG

Prednisone

1 mg/kg orally, daily for at least 30 days, then tapered over 30 days after achieving remission.

Trial Locations (1)

43210

Ohio State University, Columbus

All Listed Sponsors

collaborator

Food and Drug Administration (FDA)

FED

lead

Ohio State University

OTHER

NCT00713193 - Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP) | Biotech Hunter | Biotech Hunter